Abstract
Low serum albumin levels have been reported to be an independent predictor of increased morbidity and mortality in multiple disease conditions. The aim of our study was to identify the impact of low serum albumin levels on mortality and outcomes at discharge in patients with intracerebral hemorrhage. We retrospectively reviewed our prospective database of patients with intracerebral hemorrhage from January 2010 to December 2011. Patients were dichotomized into two groups based on their serum albumin levels upon admission. Hypoalbuminemia was defined as serum albumin levels ≤3.4 g/dl. The two groups were compared using Fisher’s exact test for categorical variables and t test for continuous variables. Poor outcome was defined as death or discharge to a long-term nursing facility (modified Rankin Score 4–6). Out of 97 patients admitted with intracerebral hemorrhage, 90 met our inclusion criteria (42 had normal levels and 48 had hypoalbuminemia). The baseline characteristics, risk factors, etiology, location and volume of intracerebral hemorrhage, admission blood glucose, white cell count, length of hospital stay, length of intensive care unit stay, and complications were similar between both groups. Although admission hypoalbuminemia did not impact in-hospital mortality (28 vs 24 %, p = 0.635), there was a significant increase in poor outcomes at discharge (59 vs 31 %, p = 0.009) (OR 1.8; 95 % CI; 1.2–2.8). Similar to other diseases, hypoalbuminemia was associated with poor functional outcomes in patients with intracerebral hemorrhage. This will need to be confirmed in larger prospective studies before adopting therapeutic and preventive strategies in future.
Similar content being viewed by others
References
McCluskey A, Thomas AN, Bowles BJ, Kishen R (1996) The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia 51:724–727
Ryan TA, Rady MY, Bashour CA, Leventhal M, Lytle B, Starr NJ (1997) Predictors of outcome in cardiac surgical patients with prolonged intensive care stay. Chest 112:1035–1042
Becker BN, Becker YT, Heisey DM, Leverson GE, Collins BH, Odorico JS, D’Alesssandro AM, Knechtle SJ, Pirsch JD, Sollinger HW (1999) The impact of hypoalbuminemia in kidney-pancreas transplant recipients. Transplantation 68:72–75
Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM (2003) Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 237:319–334
Nicholson JP, Wolmarans MR, Park GR (2000) The role of albumin in critical illness. Br J Anaesth 85:599–610
Demling RH (1986) Effect of plasma and interstitial protein content on tissue edema formation. Curr Stud Hematol Blood Transfus 53:36–52
Jorgensen KA, Stoffersen E (1980) On the inhibitory effect of albumin on platelet aggregation. Thromb Res 17:13–18
Dziedzic T, Pera J, Slowik A, Gryz-Kurek EA, Szczudlik A (2007) Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. Eur J Clin Nutr 61:1318–1322
Cho YM, Choi IS, Bian RX, Kim JH, Han JY, Lee SG (2008) Serum albumin at admission for prediction of functional outcome in ischaemic stroke patients. Neurol Sci 29:445–449
Nilsson OG, Lindgren A, Brandt L, Saveland H (2002) Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg 97:531–536
Ganti L, Jain A, Yerragondu N, Jain M, Bellolio MF, Gilmore RM, Rabinstein A (2013) Female gender remains an independent risk factor for poor outcome after acute nontraumatic intracerebral hemorrhage. Neurol Res 2013:219097
Ji R, Shen H, Pan Y, Wang P, Liu G, Wang Y et al (2013) A novel risk score to predict 1-year functional outcome after intracerebral hemorrhage and comparison with existing scores. Crit Care 17:R275
Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G (1993) Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24:987–993
Stead LG, Jain A, Bellolio MF, Odufuye A, Gilmore RM, Rabinstein A et al (2010) Emergency Department hyperglycemia as a predictor of early mortality and worse functional outcome after intracerebral hemorrhage. Neurocrit Care 13:67–74
Fortes Lima TT, Prandini MN, Gallo P, Cavalheiro S (2012) Prognostic value of intraventricular bleeding in spontaneous intraparenchymal cerebral hemorrhage of small volume: a prospective cohort study. Neurosurgery 70:929–934 discussion 34-5
Stein M, Luecke M, Preuss M, Boeker DK, Joedicke A, Oertel MF (2010) Spontaneous intracerebral hemorrhage with ventricular extension and the grading of obstructive hydrocephalus: the prediction of outcome of a special life-threatening entity. Neurosurgery 67:1243–1251 discussion 52
Cutting S, Castro C, Lee VH, Prabhakaran S (2014) Impaired renal function is not associated with increased volume of intracerebral hemorrhage. J Stroke Cerebrovasc Dis 23:86–90
Sakamoto Y, Koga M, Yamagami H, Okuda S, Okada Y, Kimura K et al (2013) Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. Stroke 44:1846–1851
Babu MS, Kaul S, Dadheech S, Rajeshwar K, Jyothy A, Munshi A (2013) Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. Nutrition 29:872–875
Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, Tang WW, Methvin A, Smith AL et al (2010) Serum albumin concentration and heart failure risk The Health, Aging, and Body Composition Study. Am Heart J 160:279–285
Gillum RF, Ingram DD, Makuc DM (1994) Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 140:876–888
Toyoda K, Ninomiya T (2014) Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol 13:823–833
Toyoda K (2013) Cerebrorenal interaction and stroke. Contrib Nephrol 179:1–6
Yahalom G, Schwartz R, Schwammenthal Y, Merzeliak O, Toashi M, Orion D et al (2009) Chronic kidney disease and clinical outcome in patients with acute stroke. Stroke 40:1296–1303
Ginsberg MD, Palesch YY, Hill MD, Martin RH, Moy CS, Barsan WG et al (2013) High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol 12:1049–1058
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Ethical approval
This study was ethically approved by the Instititutional Review Board at our University.
Informed consent
For this type of study formal consent was not required.
Rights and permissions
About this article
Cite this article
Limaye, K., Yang, J.D. & Hinduja, A. Role of admission serum albumin levels in patients with intracerebral hemorrhage. Acta Neurol Belg 116, 27–30 (2016). https://doi.org/10.1007/s13760-015-0504-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-015-0504-2